Phase 2 human clinical trial shows that metabolic activators improve cognitive function in Alzheimer’s disease patients
ScandiBio Therapeutics announced Phase 2 clinical trial results from the study on the open-access server medRxiv.org. The study: Combined Metabolic Activators Improves Cognitive Functions in Alzheimer’s…